Endocrine consequences of danazol treatment in menorrhagia

J Guoth, Ferenc Olajos, F Olajos, B Zsolnai
European Journal of Obstetrics & Gynecology and Reproductive Biology · 1986 · vol. 23(1-2) , pp. 79–83 · doi:10.1016/0028-2243(86)90108-5 · PMID:2946616 · W2008713077
Non-randomised trial OA: bronze CC0 ⤵ 3 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study investigated the endocrine effects of danazol treatment in patients experiencing menorrhagia, analyzing hormonal changes and their impact on the condition.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In order to study the endocrine side-effects of danazol, 15 patients with severe, benign menorrhagias, were individually treated with this drug to stop bleeding. LH, FSH, testosterone, free testosterone, DES-S, androstenedione, prolactin, estradiol and cortisol serum concentrations were measured before and after the 3 month treatment period. Danazol was found to be effective in reducing the amount of bleeding in patients with benign, severe menorrhagias; however, the weight gain of patients was significant during the 3 month period. LH and estradiol concentrations decreased; testosterone, free testosterone and dehydroepiandrosterone sulfate increased; prolactin, FSH, androstenedione and cortisol serum concentrations did not change, and SHBG disappeared from the serum, during the treatment period. We are of the opinion that danazol is an effective drug in menorrhagias with side-effects. In our view the hyperandrogenicity is the most important side-effect of this substance, which might be the result of some metabolites, but which might be the effect of a peripheral action of the drug as well.

My notes (saved in your browser only)

MeSH descriptors

Danazol Hormones Menorrhagia Pregnadienes Adult Androstenedione Androstenedione Body Weight Body Weight Danazol Danazol Dehydroepiandrosterone Dehydroepiandrosterone Dehydroepiandrosterone Dehydroepiandrosterone Sulfate Estradiol Estradiol Female Follicle Stimulating Hormone Follicle Stimulating Hormone

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (23)

Cited by (3)

Source provenance

openalex
last seen: 2026-05-10T10:55:33.458592+00:00
pubmed
last seen: 2026-10-08T21:21:33.560900+00:00
License: CC0 · commercial use OK